An Observational Study of BOTOX® as Headache Prophylaxis for Chronic Migraine

Study Identifier
MAF/AGN/NS/CM/002
CT.gov Identifier
NCT01686581
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Migraine - General
    • Study Drug
  • botulinum toxin Type A
    • Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    \- Prescribed BOTOX® for the prophylaxis of headaches.
    Exclusion Criteria:
    * Received treatment with any botulinum toxin Type A serotype in the last 26 weeks * Current participation in Allergan's Botox Chronic Migraine Post-Authorisation Safety Study (protocol 191622-110).

    Protocol Summary

    This is an observational study to describe the long term use of Onabotulinumtoxin A (BOTOX®) as prescribed by the physician for headache prophylaxis in adults with chronic migraine. All treatment decisions lie with the physician.

    Study Locations

    Location
    Status
    Location
    Nicole Strickling
    Aachen, Germany, 52062
    Status
    Not applicable
    Location
    Manfred Oberling
    Bad Camberg, Germany, 65520
    Status
    Not applicable
    Location
    Kathrin Krome
    Bamberg, Germany, 96052
    Status
    Not applicable
    Location
    Heike Förster
    Baunatal, Germany, 34225
    Status
    Not applicable
    Location
    MVZ Schmerzzentrum Berlin
    Berlin, Germany, 10435
    Status
    Not applicable
    Location
    Christoph Engelmann
    Berlin, Germany, 12099
    Status
    Not applicable
    Showing {first} - {last} of {total} Results